![Donald James Scotti](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Donald James Scotti formerly worked at Sweet Spot Productions, Inc., as President & Chief Executive Officer in 2010, Sycamore Entertainment Group, Inc., as President & Director, ImaRx Therapeutics, Inc., as President in 2010, Kaleidoscope Films Group LLC, as Vice President & Producer in 2005, and After Dark Films, as Executive Vice President.
Eerdere bekende functies van Donald James Scotti
Bedrijven | Functie | Einde |
---|---|---|
ImaRx Therapeutics, Inc.
![]() ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | President | 29-11-2010 |
Sweet Spot Productions, Inc. | President | 01-01-2010 |
Kaleidoscope Films Group LLC | Corporate Officer/Principal | 01-01-2005 |
After Dark Films | Corporate Officer/Principal | - |
SYCAMORE ENTERTAINMENT GROUP, INC. | President | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SYCAMORE ENTERTAINMENT GROUP, INC. | Consumer Services |
Bedrijven in privébezit | 4 |
---|---|
ImaRx Therapeutics, Inc.
![]() ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Health Technology |
Sweet Spot Productions, Inc. | |
Kaleidoscope Films Group LLC | |
After Dark Films |